Paracetamolo FederFarma may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paracetamolo FederFarma in the following countries:
International Drug Name Search
Generic Name: glutamine (Oral route)
GLOO-ta-meen
In the U.S.
Available Dosage Forms:
Therapeutic Class: Amino Acid Supplement
Glutamine is a substance naturally produced in the body to help regulate cell growth and function. There may also be man-made versions of these substances. Glutamine is used along with human growth hormone and a specialized diet to treat short bowel syndrome
This medicine is available only with your doctor's prescription.
For good health, it is important that you eat a balanced and varied diet. Follow carefully any diet program your health care professional may recommend. For your specific dietary vitamin and/or mineral needs, ask your health care professional for a list of appropriate foods. If you think that you are not getting enough vitamins and/or minerals in your diet, you may choose to take a dietary supplement.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of glutamine in children with use in other age groups.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of glutamine in the elderly with use in other age groups. However, elderly patients are more likely to be sensitive requiring the need for dosage adjustment.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain glutamine. It may not be specific to Resource Glutasolve. Please read with care.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check you at regular visits.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Resource Glutasolve side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Brusal may be available in the countries listed below.
Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Brusal in the following countries:
International Drug Name Search
Generic Name: chlorpheniramine and phenylephrine (KLOR fen IR a meen and FEN il EFF rin)
Brand Names: Actifed Cold & Allergy, Allan Tannate Pediatric, Allerest PE, AlleRx, BP Allergy JR, C Phen, Cardec, Ceron, Chlor-Mes Jr, ChlorTan D, Cold & Allergy Relief, CP Dec, Dallergy Drops, Dallergy-JR, Dec-Chlorphen, Ed A-Hist, Ed ChlorPed D, Histadec, Nasohist Pediatric, NoHist, Ny-Tannic, PD-Hist D, PD-Hist D Drops, PediaTan D, Phenchlor Tannate Pediatric, R-Tanna, Relera, Rinate Pediatric, Rondec, Rondex, Rynatan, Rynatan Pediatric, Sildec-PE, Sinus & Allergy Maximum Strength, Sinus & Allergy PE, Sonahist, Sudafed PE Sinus & Allergy, Tanahist-D, Triaminic Cold & Allergy
Chlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).
The combination of chlorpheniramine and phenylephrine is used to treat symptoms of the common cold or seasonal allergies, including sneezing, runny or stuffy nose, and itchy, watery eyes.
Chlorpheniramine and phenylephrine may also be used for purposes not listed in this medication guide.
There are many brands and forms of this medication available and not all brands are listed on this leaflet.
Do not use this medication during an asthma attack.
Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.
severe or uncontrolled high blood pressure;
severe coronary artery disease;
narrow angle glaucoma;
a stomach ulcer;
if you are unable to urinate; or
if you are having an asthma attack.
Ask a doctor or pharmacist if it is safe for you to take this medication if you have:
diabetes;
glaucoma;
circulation problems;
heart disease or high blood pressure;
overactive thyroid;
a seizure disorder such as epilepsy;
asthma, emphysema or chronic bronchitis; or
urination problems or an enlarged prostate.
Artificially sweetened liquid cold medicine may contain phenylalanine. If you have phenylketonuria (PKU), check the medication label to see if the product contains phenylalanine.
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.
The chewable tablet must be chewed before swallowing.
Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.
This medication can cause unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.
If you need surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.
Since cold medicine is taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include some of the serious side effects listed in this medication guide.
Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.
fast or pounding heartbeats;
confusion, hallucinations, unusual thoughts or behavior;
severe dizziness, anxiety, restless feeling, nervousness;
urinating less than usual or not at all;
easy bruising or bleeding, unusual weakness; or
seizure (black-out or convulsions).
Less serious side effects may include:
blurred vision;
dry nose or mouth;
nausea, stomach pain, constipation, loss of appetite;
dizziness, drowsiness;
problems with memory or concentration;
ringing in your ears; or
feeling restless or excited (especially in children).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1 800 FDA 1088.
Tell your doctor about all other medications you use, especially:
mecamylamine (Inversine);
methyldopa (Aldomet);
reserpine;
a beta-blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others;
a barbiturate such as butabarbital (Butisol), secobarbital (Seconal), pentobarbital (Nembutal), or phenobarbital (Solfoton); or
an antidepressant such as amitriptyline (Elavil, Vanatrip), doxepin (Sinequan), nortriptyline (Pamelor), and others.
This list is not complete and other drugs may interact with chlorpheniramine and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Rinate Pediatric side effects (in more detail)
Generic Name: Methocarbamol
Class: Centrally Acting Skeletal Muscle Relaxants
VA Class: MS200
Chemical Name: 1-Carbamate-3-(2-methoxyphenoxy)-1,2-propanediol
Molecular Formula: C11H15NO5
CAS Number: 532-03-6
Centrally acting skeletal muscle relaxant.b
Adjunct to rest, physical therapy, analgesics, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.a b c
For low back pain, generally reserve skeletal muscle relaxants for adjunctive treatment when pain is unresponsive to OTC analgesics (e.g., NSAIAs).h i j k l m
Skeletal muscle relaxants less well tolerated than NSAIAs, and clinical superiority to NSAIAs not established for low back pain.h i j k l m
Various skeletal muscle relaxants appear to have comparable efficacy for low back pain reliefg h and are more effective than placebo.h j l
Initially, symptomatic control of acute low back pain focuses on providing sufficient comfort to allow maximum possible activity while awaiting spontaneous recovery; later, as aid to overcome specific activity intolerance.l
Because of rapid spontaneous recovery rate, efficacy of various therapies may be difficult to establish;l improvement of low back pain usually occurs within 2 weeks, substantial improvement within 4 weeks.k
Ineffective in the treatment of skeletal muscle hyperactivity secondary to chronic neurologic disorders (e.g., cerebral palsy) and other dyskinesias.b
Has been used as an adjunct to debridement, tetanus antitoxin, penicillin, tracheotomy, fluid and electrolyte replacement, and supportive therapy in the management of tetanus.b However, most authorities prefer other sedatives or muscle relaxants (e.g., diazepam) and, in severe cases, neuromuscular blocking agents.b
Administer orally; may administer IV or IM when oral administration is not feasible or for severe musculoskeletal pain.a b c Do not administer sub-Q.b
Switch from parenteral to oral therapy as soon as possible.b
For administration via NG tube, crush tablets and suspend in water or saline solution.b c
For solution compatibility information, see Compatibility under Stability.
Administer by direct IV injection or by IV infusion.b c
Patient should be recumbent during and for 10–15 minutes following IV administration.b
Avoid extravasation; solution is hypertonic.b c
For direct IV use, inject undiluted solution slowly to minimize adverse effects.b c
Blood aspirated into syringe does not mix with methocarbamol injection; either inject any blood in the syringe or stop the injection when the plunger reaches the blood.b c
For IV infusion, dilute 1 g with up to 250 mL of 5% dextrose or 0.9% sodium chloride injection.b c
Visually inspect diluted solutions for haze prior to administration.b (See Stability.)
For direct IV injection, maximum rate of 300 mg (3 mL of 10% injection) per minute.b c Some clinicians have recommended injection at rate of 180 mg/m2 per minute in children.b
Administer no more than 500 mg (5 mL of 10% injection) into each gluteal region.b c
Children ≥12 years of age: Recommended minimum initial dose is 15 mg/kg or 500 mg/m2; give additional doses of 15 mg/kg or 500 mg/m2 by direct IV injection or IV infusion every 6 hours, if necessary (maximum 1.8 g/m2 daily for 3 consecutive days).b c
Usual initial dosage is 1.5 g 4 times daily for 2–3 days.a b For maintenance, decrease dosage to 4–4.5 g daily in 3–6 divided doses.a b
A few patients may require initial dosage of 8 g daily in divided doses.a b
Usually, 1 g as a single dose, followed by oral methocarbamol to maintain relief.b c
For more severe conditions or when oral administration is not feasible, 1 g every 8 hours (maximum 3 g daily for 3 consecutive days).b c If necessary, may readminister IV or IM after a 2-day drug-free interval.a c
Usual initial dose is 1–2 g by direct IV injection; may administer additional 1–2 g by IV infusion (for maximum total initial dose of 3 g).b c
Repeat IV infusion of 1–2 g every 6 hours until NG tube can be inserted.b c Up to 24 g daily (via NG tube) may be required.b c
Maximum 1.8 g/m2 daily for 3 consecutive days.b c
Maximum 3 g daily for 3 consecutive days.b c
Injection contraindicated in patients with impaired renal function.b c (See Renal Impairment under Cautions.)
Known hypersensitivity to methocarbamol or any ingredient in the formulation.a b c
Performance of activities requiring mental alertness or physical coordination may be impaired.a b c
Possible additive effect with other CNS depressants and/or alcohol.a b c (See Specific Drugs and Laboratory Tests under Interactions.)
Anaphylactic reactions, urticaria, pruritus, rash, skin eruptions, and conjunctivitis with nasal congestion have occurred.a b c
The stopper of the methocarbamol injection (Robaxin) vial contains dry natural rubber (latex).c Some individuals may be hypersensitive to natural latex proteins.c d e f Take appropriate precautions if injection is handled by or administered to individuals with a history of latex sensitivity.c
Use IV or IM with caution, if at all, in patients with known or suspected epilepsy.b c
Category C.a b c
Distributed into milk in dogs; not known whether distributed into human milk.a b c Use caution.a b c
Safety and efficacy (other than IV use in the management of tetanus) not established in children.a b c
Polyethylene glycol vehicle of methocarbamol injection may be irritating to the kidneys; may worsen preexisting acidosis and urea retention.b c Do not administer to patients with impaired renal function.b c
Drowsiness, dizziness, lightheadedness.a b c
Drug or Test | Interaction | Comments |
|---|---|---|
Anticholinesterase agents (e.g., pyridostigmine) | Potential for severe weaknessa b c | Use with caution in patients with myasthenia gravisa b c |
CNS depressants (e.g., alcohol) | Potential for additive CNS depressiona b c | Use caution to avoid overdosagea b c |
Tests for 5-hydroxyindolacetic acid (5-HIAA) in urine (nitrosonaphthol reagent in quantitative method of Udenfriend) | False-positive results (color interference) a b c | |
Tests for vanillylmandelic acid (VMA) in urine by the screening method of Gitlow | False-positive results (color interference)a b c |
Rapidly and almost completely absorbed following oral administration.b
Usually within 30 minutes following oral administration.b
Almost immediate after IV administration.b
Widely distributed in dogs, with highest concentrations in the kidney and liver.b
Methocarbamol and/or its metabolites cross the placenta in dogs.b
Distributed into milk in dogs; not known whether distributed into human milk.a b c
46–50%.a c
Extensively metabolized, presumably in the liver, by dealkylation and hydroxylation.b
Eliminated principally in urine as metabolites (40–50% as glucuronide and sulfate conjugates, remainder as unidentified metabolites); small amount (10–15%) eliminated unchanged in urine.b Very small amounts excreted in feces.b
0.9–1.8 hours.b
In geriatric patients, half-life slightly prolonged.a c
In patients with renal impairment on maintenance dialysis, clearance decreased by 40% but no apparent increase in half-life.a c
In patients with cirrhosis secondary to alcohol abuse, clearance decreased by 70% and half-life increased to about 3.4 hours.a c
Tight containers at 20–25°C.a
20–25°C (may be exposed to 15–30°C).b c Do not freeze.b
Do not refrigerate after dilution (see Compatibility under Stability).b c
For information on systemic interactions resulting from concomitant use, see Interactions.
Precipitation and haze formation may occur if diluted solution is refrigerated.b c
Haze formation in diluted solutions may be unpredictable; visually inspect all diluted solutions prior to administration regardless of storage conditions.b
Compatible |
|---|
Dextrose 5% in waterc |
Sodium chloride 0.9%c |
CNS depressant with sedative and skeletal muscle relaxant effects.a b c
Precise mechanism of action is not known; does not directly relax skeletal muscle and has minimal skeletal muscle relaxant effects.a b c Beneficial effect probably is related to the drug’s sedative effect.a b c
Unlike neuromuscular blocking agents, does not depress neuronal conduction, neuromuscular transmission, or muscle excitability.b
Potential to impair mental alertness or physical coordination, especially with concomitant use of alcohol or other CNS depressants; use caution when driving or operating machinery.a b c
Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs and dietary or herbal supplements, as well as concomitant illnesses.a b c
Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.a b
Importance of informing patients of other important precautionary information. (See Cautions.)
Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.
* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name
Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
|---|---|---|---|---|
Oral | Tablets | 500 mg* | Methocarbamol Tablets | Global, Sandoz, United Research, Watson, West-Ward |
750 mg* | Methocarbamol Tablets | Global, Sandoz, United Research, Watson, West-Ward | ||
Tablets, film-coated | 500 mg | Robaxin (with povidone and propylene glycol) | Schwarz | |
750 mg | Robaxin (with povidone and propylene glycol) | Schwarz | ||
Parenteral | Injection | 100 mg/mL | Robaxin (with 50% polyethylene glycol 300) | Baxter |
This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 03/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.
Methocarbamol 500MG Tablets (QUALITEST): 60/$14.97 or 120/$23.94
Robaxin 500MG Tablets (ACTIENT PHARMACEUTICALS): 30/$59.99 or 90/$149.96
Robaxin-750 750MG Tablets (ACTIENT PHARMACEUTICALS): 30/$75.99 or 90/$200.98
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions April 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
a. Schwarz Pharma. Robaxin and Robaxin-750 tablets prescribing information. Milwaukee, WI; 2003 Apr.
b. AHFS Drug Information 2004. McEvoy GK, ed. Methocarbamol. Bethesda, MD: American Society of Health-System Pharmacists; 2004: 1336-7.
c. Baxter. Robaxin injection prescribing information. Deerfield, IL; 2003 Nov.
d. Food and Drug Administration. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices. 21 CFR Part 801. Final rule. (Docket No. 96N-0119) Fed Regist. 1998; 63:50660-704.
e. Food and Drug Administration. Latex-containing devices; user labeling. 21 CFR Part 801. Proposed rule. (Docket No. 96N-0119) Fed Regist. 1996; 61:32617-21.
f. Food and Drug Administration. Natural rubber-containing medical devices; user labeling. 21 CFR Part 801. Final rule. (Docket No. 96N-0119) Fed Regist. 1997; 62:51021-30.
g. McNeil. Cyclobenzaprine hydrochloride (Flexeril) tablets prescribing information. Fort Washington, PA: 2003 Feb.
h. van Tulder MW, Touray T, Furlan AD et al. Muscle relaxants for non-specific low back pain. The Cochrane Library. From their web site (). Accessed 11/10/2003.
i. van Tulder MW, Scholten RJPM, Kowes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. The Cochrane Library. From their web site (). Accessed 11/10/2003.
j. Department of Veterans Affairs Veterans Health Administration Office of Quality & Performance. Management of Person with Low Back Pain/Sciatica in Primary Care. From the web site (). Accessed 8/25/2003.
k. Agency for Healthcare Research and Quality. Adult low back pain. From the National Guideline Clearinghouse website. (). Accessed 8/25/2003.
l. U.S. Department of Health and Human Services. Public Health Service. Agency for Halath Care Policy and Research. Acute low back problems in adults. Clinical Practice Guideline.1994; No. 14
m. U.S. Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research. Acute low back problems in adults: Assessment and treatment. Clinical Practice Guideline. Quick Reference Guide for Clinicians.1994; No. 14
Generic Name: morphine (MOR feen)
Brand Names: AVINza, Kadian, Morphine IR, MS Contin, MSIR, Oramorph SR, Roxanol
Morphine is a narcotic pain reliever.
Morphine is used to treat moderate to severe pain. Short-acting morphine is taken as needed for pain. Extended-release morphine is for use when around-the-clock pain relief is needed.
Morphine is not for treating pain just after surgery unless you were already taking morphine before the surgery.
Morphine may also be used for purposes not listed in this medication guide.
You may not be able to take this medicine unless you are already being treated with a similar opioid pain medicine and your body is tolerant to it. Talk with your doctor if you are not sure you are opioid-tolerant.
Never take morphine in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.
To make sure you can safely take morphine, tell your doctor if you have any of these other conditions:
a blockage in your digestive tract (stomach or intestines);
asthma, COPD, sleep apnea, or other breathing disorders;
underactive thyroid;
curvature of the spine;
a history of head injury or brain tumor;
epilepsy or other seizure disorder;
low blood pressure;
gallbladder disease;
Addison's disease or other adrenal gland disorders;
enlarged prostate, urination problems;
mental illness; or
a history of drug or alcohol addiction.
Older adults and those who are ill or debilitated may be more likely to have serious side effects.
Take exactly as prescribed. Never take morphine in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.
To make swallowing easier, you may open the extended-release capsule and sprinkle the medicine into a spoonful of applesauce. Swallow this mixture right away without chewing. Do not save the mixture for later use. Discard the empty capsule.
Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
Keep track of how many pills have been used from each new bottle of this medicine. Morphine is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.
Always check your bottle to make sure you have received the correct pills (same brand and type) of medicine prescribed by your doctor. Ask the pharmacist if you have any questions about the medicine you receive at the pharmacy.
After you have stopped using this medication, flush any unused pills down the toilet. Throw away any unused liquid morphine that is older than 90 days.
Since morphine is sometimes used as needed, you may not be on a dosing schedule. If you are using the medication regularly, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Do not use extra medicine to make up the missed dose.
Overdose symptoms may include extreme drowsiness, pinpoint pupils, confusion, cold and clammy skin, weak pulse, shallow breathing, fainting, or breathing that stops.
shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.
Less serious side effects may include:
constipation;
warmth, tingling, or redness under your skin;
nausea, vomiting, stomach pain, diarrhea, loss of appetite;
dizziness, headache, anxiety;
memory problems; or
sleep problems (insomnia).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your doctor about all other medicines you use, especially:
cimetidine (Tagamet);
buprenorphine (Buprenex, Subutex);
butorphanol (Stadol);
nalbuphine (Nubain);
pentazocine (Talwin); or
a diuretic (water pill).
This list is not complete and other drugs may interact with morphine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: Roxanol side effects (in more detail)
re-SOR-si-nol
In the U.S.
Available Dosage Forms:
Therapeutic Class: Analgesic
Resorcinol is used to treat acne, seborrheic dermatitis, eczema, psoriasis, and other skin disorders. It is also used to treat corns, calluses, and warts.
Resorcinol works by helping to remove hard, scaly, or roughened skin.
Some of these preparations are available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For resorcinol, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to resorcinol or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Resorcinol may be absorbed through the skin and should not be used on large areas of the bodies of infants and children. In addition, resorcinol should not be used on wounds, since doing so may cause a blood disease called methemoglobinemia.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of resorcinol in the elderly with use in other age groups, resorcinol is not expected to cause different side effects or problems in older people than it does in younger adults.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
It is very important that you use resorcinol only as directed. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may increase the chance of absorption through the skin and the chance of resorcinol poisoning.
Apply enough resorcinol to cover the affected areas, and rub in gently.
Immediately after using resorcinol, wash your hands to remove any medicine that may be on them.
Keep resorcinol away from the eyes. If you should accidentally get some in your eyes, flush them thoroughly with water.
The dose of resorcinol will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of resorcinol. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of resorcinol, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
When using resorcinol, do not use any of the following preparations on the same affected area as resorcinol, unless otherwise directed by your doctor:
To use any of the above preparations on the same affected area as resorcinol may cause severe irritation of the skin.
resorcinol may darken light-colored hair.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
